1. Home
  2. DERM vs AIRS Comparison

DERM vs AIRS Comparison

Compare DERM & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$6.15

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Logo AirSculpt Technologies Inc.

AIRS

AirSculpt Technologies Inc.

HOLD

Current Price

$1.96

Market Cap

182.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DERM
AIRS
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.3M
182.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DERM
AIRS
Price
$6.15
$1.96
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $12.67
N/A
AVG Volume (30 Days)
156.5K
★ 869.4K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 34.72
N/A
EPS
N/A
★ N/A
Revenue
$61,858,000.00
★ $151,818,000.00
Revenue This Year
$39.72
$5.19
Revenue Next Year
$63.24
$5.32
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 10.20
N/A
52 Week Low
$4.31
$1.51
52 Week High
$9.56
$12.00

Technical Indicators

Market Signals
Indicator
DERM
AIRS
Relative Strength Index (RSI) 32.17 32.82
Support Level $5.92 $1.85
Resistance Level $6.59 $3.36
Average True Range (ATR) 0.43 0.19
MACD -0.17 0.02
Stochastic Oscillator 0.53 7.60

Price Performance

Historical Comparison
DERM
AIRS

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

Share on Social Networks: